Resonate Blends Business Summary

Apollo Biowellness, Inc. (formerly Resonate Blends, Inc.) is a vertically integrated life sciences company specializing in the discovery, development, and commercialization of regenerative medicine and biologic-based wellness products. The company generates revenue primarily through transaction-based sales of its proprietary "Evo Bio" brand—a line of mesenchymal stem cell-derived exosomes and placental-based biologics—targeting the professional medical aesthetics market, including plastic surgeons, dermatologists, and med spas. Its business is organized into three primary segments: Professional Biologics (Evolutionary Biologics), Consumer Cosmetics (Cielo Skin Care), and a nascent Pet Health division focused on placental-based treatments for joint and post-surgical recovery. In the competitive landscape of exosome therapeutics and regenerative aesthetics, Apollo Biowellness competes directly with firms such as Kimera Labs, Aegle Therapeutics, and Capricor Therapeutics, positioning itself as a niche provider of shelf-stable, cell-free biologic solutions that bypass the logistical hurdles of traditional cryopreserved stem cell therapies. Leadership is anchored by Founder and CEO Jim Morrison, a veteran of the beauty and wellness industry with a pedigree that includes serving as President of L'Oreal’s Matrix division and CEO of Sexy Hair. He is supported by President James W. Zimbler, who oversees corporate restructuring and capital markets strategy. The company’s Board of Directors features notable figures such as Jay Lucas, Chairman of The Lucas Group and former Vice President at Bain & Company, and Bobby Carpenter, a former NFL linebacker and MBA consultant. Strategic scientific guidance is provided by Advisory Board member Colleen Quinn, an internationally recognized clinical aromatherapist and researcher specializing in synergistic plant-based formulations. This leadership team is currently focused on reclaiming direct brand management following the February 2026 termination of its exclusive distribution agreement with Revive Regenerative, shifting toward a multi-channel distribution model supported by institutional backing from LB Equity Health and Wellness Fund.